Human basophil/mast cell releasability: IX. Heterogeneity of the effects of opioids on mediator release

C. Stellato, R. Cirillo, A. De Paulis, V. Casolaro, V. Patella, P. Mastronardi, B. Mazzarella, G. Marone

Research output: Contribution to journalArticlepeer-review

Abstract

Opioids differ in their capacity to cause release of histamine. The effects of increasing concentrations of three opioids (morphine, buprenorphine, and fentanyl) were studied on the release of preformed (histamine and tryptase) and de novo synthesized (prostaglandin D2 [PGD2] and peptide-leukotriene C4 [LTC4]) chemical mediators from human peripheral blood basophils and mast cells isolated from skin tissues or lung parenchyma. Basophils released <5% of their histamine content and did not synthesize significant amounts of LTC4 when incubated with any of the opioids. Mast cells showed markedly different responses to the three opioids. Morphine (10-5-3 x 10-4 M), in a concentration-dependent manner, induced histamine and tryptase release from skin but not from lung mast cells, up to a maximum of 18.2 ± 1.9% and 13.0 ± 4.1 μg/107 cells, respectively. Morphine did not induced de novo synthesis of PGD2 from skin mast cells. Buprenorphine (10-6-10-4 M), in a concentration-dependent manner, caused histamine and tryptase release from lung but not from skin mast cells, to a maximum of 47.6 ± 7.2% and 35.1 ± 13.6 μg/107 cells, respectively. Buprenorphine also induced de novo synthesis of PGD2 and LTC4 from lung mast cells. Fentanyl (10-5-10-3 M) did not induce histamine and tryptase release or the de novo synthesis of PGD2 or LTC4 from any mast cells. Histamine release caused by buprenorphine from lung mast cells was slow (t 1/2 = 11.2 ± 3.6 min) compared with that induced by morphine from skin mast cells (t 1/2 <1 min, P <0.001). The releasing activity of buprenorphine on lung mast cells was abolished by lowering the temperature of the incubation buffer to 22° C and 4° C. Buprenorphine's capacity to induce histamine release from lung mast cells was partially dependent on extracellular Ca2+ and was not reduced by metabolic impairment caused by preincubation (15-40 min) with 2-deoxy-D- glucose plus antimycin A. Thus, there appear to be functional differences between human basophils and mast cells and between mast cells from different anatomic sites in response to the three opioids tested.

Original languageEnglish (US)
Pages (from-to)932-940
Number of pages9
JournalAnesthesiology
Volume77
Issue number5
DOIs
StatePublished - 1992
Externally publishedYes

Keywords

  • Analgesics, opioid: buprenorphine; fentanyl; morphine
  • Cells: basophils; mast cells
  • Enzymes: tryptase
  • Leukotriene C
  • Medication: histamine
  • Prostaglandin D

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Human basophil/mast cell releasability: IX. Heterogeneity of the effects of opioids on mediator release'. Together they form a unique fingerprint.

Cite this